Mycobacterium tuberculosis Universal Stress Protein Rv2623 Regulates Bacillary Growth by ATP-Binding: Requirement for Establishing Chronic Persistent Infection

Autor: Kaixia Mi, Guofeng Zhu, Ian M. Orme, Jo Ann M. Tufariello, Randall J. Basaraba, Angelo Izzo, Joshua E. Drumm, Patrick W. Bilder, Jihyeon Lim, Helle Bielefeldt-Ohmann, Steve C. Almo, Meihao Sun, Thomas S. Leyh, John Chan, Melvin So
Rok vydání: 2009
Předmět:
lcsh:Immunologic diseases. Allergy
Pathology/Histopathology
Tuberculosis
Guinea Pigs
Immunology
Mutant
Crystallography
X-Ray

Microbiology
Biochemistry/Protein Folding
Infectious Diseases/Bacterial Infections
Pathogenesis
Mycobacterium tuberculosis
Mice
03 medical and health sciences
Adenosine Triphosphate
Bacterial Proteins
Biochemistry/Protein Chemistry
In vivo
Virology
Genetics
medicine
Animals
lcsh:QH301-705.5
Molecular Biology
030304 developmental biology
0303 health sciences
Microbiology/Microbial Growth and Development
biology
030306 microbiology
Gene Expression Regulation
Bacterial

Phosphate-Binding Proteins
medicine.disease
biology.organism_classification
In vitro
3. Good health
Chronic infection
lcsh:Biology (General)
Chronic Disease
Parasitology
lcsh:RC581-607
Microbiology/Cellular Microbiology and Pathogenesis
Carrier Proteins
Research Article
Protein Binding
Mycobacterium
Zdroj: PLoS Pathogens
PLoS Pathogens, Vol 5, Iss 5, p e1000460 (2009)
ISSN: 1553-7374
Popis: Tuberculous latency and reactivation play a significant role in the pathogenesis of tuberculosis, yet the mechanisms that regulate these processes remain unclear. The Mycobacterium tuberculosis universal stress protein (USP) homolog, rv2623, is among the most highly induced genes when the tubercle bacillus is subjected to hypoxia and nitrosative stress, conditions thought to promote latency. Induction of rv2623 also occurs when M. tuberculosis encounters conditions associated with growth arrest, such as the intracellular milieu of macrophages and in the lungs of mice with chronic tuberculosis. Therefore, we tested the hypothesis that Rv2623 regulates tuberculosis latency. We observed that an Rv2623-deficient mutant fails to establish chronic tuberculous infection in guinea pigs and mice, exhibiting a hypervirulence phenotype associated with increased bacterial burden and mortality. Consistent with this in vivo growth-regulatory role, constitutive overexpression of rv2623 attenuates mycobacterial growth in vitro. Biochemical analysis of purified Rv2623 suggested that this mycobacterial USP binds ATP, and the 2.9-Å-resolution crystal structure revealed that Rv2623 engages ATP in a novel nucleotide-binding pocket. Structure-guided mutagenesis yielded Rv2623 mutants with reduced ATP-binding capacity. Analysis of mycobacteria overexpressing these mutants revealed that the in vitro growth-inhibitory property of Rv2623 correlates with its ability to bind ATP. Together, the results indicate that i) M. tuberculosis Rv2623 regulates mycobacterial growth in vitro and in vivo, and ii) Rv2623 is required for the entry of the tubercle bacillus into the chronic phase of infection in the host; in addition, iii) Rv2623 binds ATP; and iv) the growth-regulatory attribute of this USP is dependent on its ATP-binding activity. We propose that Rv2623 may function as an ATP-dependent signaling intermediate in a pathway that promotes persistent infection.
Author Summary Mycobacterium tuberculosis poses serious threats to public health worldwide. The ability of this pathogen to establish in the host a clinically silent, persistent latent infection that can subsequently reactivate to cause diseases constitutes a major challenge in controlling tuberculosis. Our study showed that an M. tuberculosis mutant that is deficient in a universal stress protein (USP) designated Rv2623 fails to establish a chronic persistent infection in animal hosts. The mutant strain exhibits a hypervirulent phenotype as assessed by increased bacillary growth, pathology, and mortality in infected animals relative to the parental strain. Consistent with this in vivo growth-regulating attribute, we demonstrated that Rv2623, when expressed in mycobacteria at levels higher than that of the wild-type strain, retards bacterial growth in vitro. Using biochemical and biophysical analyses, including the Rv2623 crystal structure, we showed that this USP binds to ATP within a novel ATP-binding pocket. Through targeted mutagenesis studies, we further determined that the ability of Rv2623 to regulate bacillary growth is dependent on its ATP-binding capacity. Our data strongly suggest Rv2623 as a critical component that regulates the entry of M. tuberculosis into a chronic persistent growth phase, and therefore provide valuable insight into tuberculous dormancy and uncover new opportunities for the development of novel anti-tuberculous therapies.
Databáze: OpenAIRE